National Institutes of Health Axes Funding for Abortion-Based Fetal Tissue Research Amid Trump Administration Revival
In a significant shift, the National Institutes of Health (NIH) has announced that it will no longer fund research utilizing human fetal tissue obtained from "elective" abortions. This ban marks the culmination of efforts by anti-abortion advocates to eliminate such studies, which had been implemented during President Donald Trump's first term in office.
The policy change was welcomed by NIH Director Jay Bhattacharya, who stated that this decision would modernize the agency and align it with the best science of today. The move is seen as a victory for pro-life groups, who have long opposed research using tissue from abortions.
While fetal tissue obtained from miscarriages can still be used in NIH-funded research, scientists generally prefer to use tissue from abortions due to concerns over genetic abnormalities and usability issues associated with tissue collected during miscarriages.
The decision comes after the Biden administration reversed a similar policy implemented by the Trump administration. However, the NIH reports that funding for projects involving fetal tissue from abortions has decreased significantly since 2019, with only 77 projects receiving agency backing in fiscal year 2024 at a cost of $60m.
Fetal tissue research has contributed to breakthroughs in diseases such as diabetes, Alzheimer's, and infertility. It also played a role in the development and production of vaccines for polio, hepatitis A, rabies, and other illnesses.
In a significant shift, the National Institutes of Health (NIH) has announced that it will no longer fund research utilizing human fetal tissue obtained from "elective" abortions. This ban marks the culmination of efforts by anti-abortion advocates to eliminate such studies, which had been implemented during President Donald Trump's first term in office.
The policy change was welcomed by NIH Director Jay Bhattacharya, who stated that this decision would modernize the agency and align it with the best science of today. The move is seen as a victory for pro-life groups, who have long opposed research using tissue from abortions.
While fetal tissue obtained from miscarriages can still be used in NIH-funded research, scientists generally prefer to use tissue from abortions due to concerns over genetic abnormalities and usability issues associated with tissue collected during miscarriages.
The decision comes after the Biden administration reversed a similar policy implemented by the Trump administration. However, the NIH reports that funding for projects involving fetal tissue from abortions has decreased significantly since 2019, with only 77 projects receiving agency backing in fiscal year 2024 at a cost of $60m.
Fetal tissue research has contributed to breakthroughs in diseases such as diabetes, Alzheimer's, and infertility. It also played a role in the development and production of vaccines for polio, hepatitis A, rabies, and other illnesses.